MOUNTAIN VIEW, Calif., March 5, 2009 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS), a biopharmaceutical company developing innovative, next-generation therapies to address unmet needs in obesity, diabetes and sexual health, today announced that it will report financial results for the quarter and year ended December 31, 2008 after the NASDAQ Market closes on Monday, March 9, 2009. The company will conduct a conference call and an audio webcast at 1:30pm PT on the same day.
